Chronic inflammatory demyelinating polyneuropathy with positive anti-myelin associated glycoprotein antibodies: back to clinical basics

Abstract

Chronic inflammatory demyelinating polyneuropathy with anti-myelin associated glycoprotein antibodies represents a small subgroup of patients for whom management may not be straightforward. A recent study offers insight into this issue, with results suggesting priority should be given to the clinical phenotype.